- SYRE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G Filing
Spyre Therapeutics (SYRE) SC 13GAeglea BioTherapeutics, Inc.
Filed: 14 Apr 16, 12:00am
Identification number | Legal status | Entry | Cancelled | Carried CH-270.3.002.061-2 | |
from: | 1 | ||||
CHE-103.867.266 | Limited or Corporation | 01.03.1996 | on: |
All entries | ||||
In | Ca | Business name | Ref | Legal seat |
1 | Novartis AG | 1 | Basel | |
1 | 2 | |||
2 | (Novartis SA) (Novartis Inc.) |
CHE-103.867.266 | Novartis AG | Basel | 5 | |||
All entries | ||||||
In | Mo | Ca | Personal Data | Function | Signature | |
6 | Eichhorn, Felix, von Basel, in Basel | joint signature at two |
CHE-103.867.266 | Novartis AG | Basel | 8 | |||
All entries | ||||||
In | Mo | Ca | Personal Data | Function | Signature | |
73 | Rehm, Christian, von Ruschein, in Muttenz | joint signature at two |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.